Delivery Order SPE2DR25D2104-SPE2DR26F3QHF
- Not listed
- The Defense Logistics Agency awarded a $3,282.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $4,993.88 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,253.16 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 198 mg, a testosterone replacement therapy medication. The contract was competitively awarded without set-aside designation on July 21, 2025, with an ultimate completion date of July 22, 2025. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under firm fixed-price terms and...
- The Defense Logistics Agency (DLA) awarded a $1,131.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on August 19, 2025, with completion scheduled for August 20, 2025. This non-set-aside contract represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $2,326.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. The contract, issued on June 30, 2025, with an ultimate completion date of July 1, 2025, represents a non-set-aside competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location and serves as a major...
- The Defense Logistics Agency awarded a $1,581.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on November 4, 2025, with completion required by November 5, 2025. This non-set-aside contract represents a standard pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,182.21 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. This non-competitive delivery order was issued on August 13, 2025, with completion targeted for August 14, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, utilizing firm fixed price pricing under a delivery order contract type. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,131.88 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 158 mg, a pharmaceutical product. This non-set-aside, firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,421.97 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a pharmaceutical product. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.92 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 158 mg on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price, competitively awarded contract represents a small-value pharmaceutical delivery with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QHFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,095.80 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 198 mg on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The DLA Troop Support Medical contract vehicle enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Jantenzo, a testosterone replacement therapy medication, exemplifies the routine pharmaceutical procurement operations conducted under the broader prime vendor contract that provides flexible access to comprehensive medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/1/25 |